Name | Ibrutinib-MPEA |
---|
Description | Ibrutinib-MPEA (Compound 20) is ibrutinib derivative. Ibrutinib is a covalent and irreversible inhibitor of Bruton's tyrosine kinase (BTK) that has been used to treat haematological malignancies[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C32H39N9O2 |
---|---|
Molecular Weight | 581.71 |